# Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy

> **NCT00085761** · PHASE3 · TERMINATED · sponsor: **NeurogesX**

## Conditions studied

- HIV Infections
- Peripheral Nervous System Diseases
- Pain

## Interventions

- **DRUG:** Capsaicin Dermal Patch

## Key facts

- **NCT ID:** NCT00085761
- **Lead sponsor:** NeurogesX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Why stopped:** Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes
- **Last updated:** 2008-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00085761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00085761, "Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00085761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*